Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Dexcom (DXCM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,282,178
  • Shares Outstanding, K 88,844
  • Annual Sales, $ 718,500 K
  • Annual Income, $ -50,200 K
  • 36-Month Beta 0.63
  • Price/Sales 14.50
  • Price/Cash Flow N/A
  • Price/Book 23.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.14
  • Number of Estimates 11
  • High Estimate 0.22
  • Low Estimate 0.09
  • Prior Year 0.10
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
105.05 +42.33%
on 12/21/18
152.69 -2.08%
on 01/18/19
+34.91 (+30.46%)
since 12/18/18
3-Month
105.05 +42.33%
on 12/21/18
152.69 -2.08%
on 01/18/19
+16.67 (+12.55%)
since 10/18/18
52-Week
52.92 +182.54%
on 02/09/18
152.69 -2.08%
on 01/18/19
+93.24 (+165.67%)
since 01/18/18

Most Recent Stories

More News
Here's Why Momentum Investors Will Love DexCom (DXCM)

Does DexCom (DXCM) have what it takes to be a top stock pick for momentum investors? Let's find out.

DXCM : 149.52 (+0.01%)
Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?

Is (DXCM) Outperforming Other Medical Stocks This Year?

DXCM : 149.52 (+0.01%)
Will Instruments Fuel Intuitive Surgical (ISRG) Q4 Earnings?

Intuitive Surgical's (ISRG) top line in the fourth quarter of 2018 is likely to benefit from solid grow that the Instruments and Accessories segment.

BAX : 70.63 (+2.18%)
ISRG : 542.55 (+1.55%)
DXCM : 149.52 (+0.01%)
PKI : 86.40 (+2.45%)
Varian Medical (VAR) to Report Q1 Earnings: What's in Store?

Strong overseas presence and product launches are likely to aid Varian Medical's (VAR) fiscal first-quarter results.

VAR : 127.84 (+1.42%)
BAX : 70.63 (+2.18%)
DXCM : 149.52 (+0.01%)
PKI : 86.40 (+2.45%)
18.8% Return Seen to Date on SmarTrend Dexcom Call (DXCM)

SmarTrend identified an Uptrend for Dexcom (NASDAQ:DXCM) on December 31st, 2018 at $120.15. In approximately 2 weeks, Dexcom has returned 18.80% as of today's recent price of $142.74.

DXCM : 149.52 (+0.01%)
3 Medical Services Stocks to Buy in 2019: HQY, AMEH & OPGN

Here we discuss three profitable Medical Services stocks as the industry booms.

HQY : 61.22 (+5.23%)
AMEH : 19.58 (+4.20%)
OPGN : 1.70 (+0.59%)
AMZN : 1,696.20 (+0.18%)
DXCM : 149.52 (+0.01%)
AngioDynamics (ANGO) Q2 Earnings Beat on Gains From NanoKnife

AngioDynamics (ANGO) sees a solid fiscal second quarter; gains from strong segmental contributions.

ATHN : 133.83 (+0.18%)
VEEV : 106.03 (+2.49%)
ANGO : 20.88 (-0.38%)
DXCM : 149.52 (+0.01%)
Dexcom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2018 and Provides Initial 2019 Outlook

DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring ("CGM"), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2018...

DXCM : 149.52 (+0.01%)
IOT Set for Explosive Growth, These Stocks Will Benefit

HENDERSON, NV / ACCESSWIRE / January 3, 2019 / The growth potential for the IoT space and, by extension, Internet of Things stocks in general, is massive. The home market alone is expected to increase...

GOPH : 0.4701 (-4.97%)
VZ : 57.09 (+0.46%)
INOTF : 0.0169 (-15.50%)
SGH : 22.71 (-0.18%)
QCOM : 55.27 (+0.91%)
DXCM : 149.52 (+0.01%)
Here's Why Investors Should Bet on DexCom (DXCM) Right Now

A solid guidance for 2018 and lucrative deals make DexCom (DXCM) a promising investment pick.

GOOGL : 1,107.30 (+0.74%)
ITGR : 80.67 (-1.25%)
VEEV : 106.03 (+2.49%)
DXCM : 149.52 (+0.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade DXCM with:

Business Summary

Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.

See More

Key Turning Points

2nd Resistance Point 153.97
1st Resistance Point 151.75
Last Price 149.52
1st Support Level 148.24
2nd Support Level 146.95

See More

52-Week High 152.69
Last Price 149.52
Fibonacci 61.8% 114.58
Fibonacci 50% 102.81
Fibonacci 38.2% 91.03
52-Week Low 52.92

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar